Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Differences in the amount of fetal hemoglobin (HbF) that persists into adulthood affect the severity of sickle cell disease and the β-thalassemia syndromes. Genetic association studies have identified sequence variants in the gene BCL11A that influence HbF levels. Here, we examine BCL11A as a potential regulator of HbF expression. The high-HbF BCL11A genotype is associated with reduced BCL11A expression. Moreover, abundant expression of full-length forms of BCL11A is developmentally restricted to adult erythroid cells. Down-regulation of BCL11A expression in primary adult erythroid cells leads to robust HbF expression. Consistent with a direct role of BCL11A in globin gene regulation, we find that BCL11A occupies several discrete sites in the β-globin gene cluster. BCL11A emerges as a therapeutic target for reactivation of HbF in β-hemoglobin disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The retention of both HBG genes, each with slightly different promoter sequences, also contributes to nuanced regulatory control and may influence HbF levels in adults, a feature of clinical relevance in disorders like β-thalassemia and sickle cell disease [97].”
From Origin and Evolution of Genes in Eukaryotes: Mechanisms, Dynamics, and Functional Implications (2025) · cites this paper as [97]
In the citing paper
“Reducing bcl11a expression in transgenic sickle mice derepressed g-globin genes.17,18”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [17]
In the citing paper
“current treatments aim to induce the expression of non-mutated fetal hemoglobin (HbF), which is functional but transcriptionally repressed post-birth (Sankaran et al. 2008).”
From From serendipity to strategy: molecular glue degraders in cancer therapeutics (2025) · cites this paper as Sankaran et al. 2008
In the citing paper
“Further molecular studies revealed that BCL11A interacts with several erythroid regulators including GATA1, FOG1, and SOX6, and with the nucleosome remodeling and deacetylase complex (NuRD) (4, 6).”
From Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A (2013) · cites this paper as [4]
In the citing paper
“We identi fi ed numerous peptides of BCL11A and nearly all previously established interacting proteins, including FOG1, the entire NuRD complex, and the nuclear matrix protein MATRIN-3 (4).”
From Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A (2013) · cites this paper as [4]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Genome-wide association studies for complex traits: consensus, uncertainty and challenges
McCarthy, M. I., Abecasis, G. R., Cardon, L. R., Goldstein, D. B., Little, J., Ioannidis, J. P. A., & Hirschhorn, J. N. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2344 · Cited by 2,891
Self-citationA Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content Screen
Moffat, J., Grueneberg, D. A., Yang, X., Kim, S. Y., Kloepfer, A. M., Hinkle, G., Piqani, B., Eisenhaure, T. M., Luo, B., Grenier, J. K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.01.040 · Cited by 1,798
Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma
Moffatt, M. F., Kabesch, M., Liang, L., Dixon, A. L., Strachan, D., Heath, S., Depner, M., von Berg, A., Bufe, A., Rietschel, E., et al. (2007) · Nature · doi:10.1038/nature06014 · Cited by 1,604
A HapMap harvest of insights into the genetics of common disease
Manolio, T. A., Brooks, L. D., & Collins, F. S. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34772 · Cited by 889
Tsai, S.-F., Martin, D. I. K., Zon, L. I., D'Andrea, A. D., Wong, G. G., & Orkin, S. H. (1989) · Nature · doi:10.1038/339446a0 · Cited by 885
Self-citationTsang, A. P., Visvader, J. E., Turner, C. A., Fujiwara, Y., Yu, C., Weiss, M. J., Crossley, M., & Orkin, S. H. (1997) · Cell · doi:10.1016/s0092-8674(00)80318-9 · Cited by 712
Self-citationUda, M., Galanello, R., Sanna, S., Lettre, G., Sankaran, V. G., Chen, W., Usala, G., Busonero, F., Maschio, A., Albai, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711566105 · Cited by 672
Self-citationLettre, G., Sankaran, V. G., Bezerra, M. A. C., Araújo, A. S., Uda, M., Sanna, S., Cao, A., Schlessinger, D., Costa, F. F., Hirschhorn, J. N., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804799105 · Cited by 561
Self-citationA QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15
Menzel, S., Garner, C., Gut, I., Matsuda, F., Yamaguchi, M., Heath, S., Foglio, M., Zelenika, D., Boland, A., Rooks, H., et al. (2007) · Nature Genetics · doi:10.1038/ng2108 · Cited by 529
Discovery of expression QTLs using large-scale transcriptional profiling in human lymphocytes
Göring, H. H. H., Curran, J. E., Johnson, M. P., Dyer, T. D., Charlesworth, J., Cole, S. A., Jowett, J. B. M., Abraham, L. J., Rainwater, D. L., Comuzzie, A. G., et al. (2007) · Nature Genetics · doi:10.1038/ng2119 · Cited by 504
Cited by
Items 101–200 of 1,001
Stress erythropoiesis: definitions and models for its study
Paulson, R. F., Hariharan, S., & Little, J. A. (2020) · Experimental Hematology · doi:10.1016/j.exphem.2020.07.011 · Cited by 128
Huang, P., Keller, C. A., Giardine, B., Grevet, J. D., Davies, J. O. J., Hughes, J. R., Kurita, R., Nakamura, Y., Hardison, R. C., & Blobel, G. A. (2017) · Genes & Development · doi:10.1101/gad.303461.117 · Cited by 127
Stress Erythropoiesis is a Key Inflammatory Response
Paulson, R. F., Ruan, B., Hao, S., & Chen, Y. (2020) · Cells · doi:10.3390/cells9030634 · Cited by 127
Molecular and cellular mechanisms that regulate human erythropoiesis
Caulier, A., & Sankaran, V. G. (2021) · Blood · doi:10.1182/blood.2021011044 · Cited by 127
Self-citationmiRNA-embedded shRNAs for Lineage-specific BCL11A Knockdown and Hemoglobin F Induction
Guda, S., Brendel, C., Renella, R., Du, P., Bauer, D. E., Canver, M. C., Grenier, J. K., Grimson, A. W., Kamran, S. C., Thornton, J., et al. (2015) · Molecular Therapy · doi:10.1038/mt.2015.113 · Cited by 123
Self-citationInnovative solutions to novel drug development in mental health
Insel, T. R., Voon, V., Nye, J. S., Brown, V. J., Altevogt, B. M., Bullmore, E. T., Goodwin, G. M., Howard, R. J., Kupfer, D. J., Malloch, G., et al. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.03.022 · Cited by 124
The first trimester human placenta is a site for terminal maturation of primitive erythroid cells
Van Handel, B., Prashad, S. L., Hassanzadeh-Kiabi, N., Huang, A., Magnusson, M., Atanassova, B., Chen, A., Hamalainen, E. I., & Mikkola, H. K. A. (2010) · Blood · doi:10.1182/blood-2010-04-279489 · Cited by 107
Self-citationDeciphering the impact of genomic variation on function
IGVF Consortium, Writing group (ordered by contribution), Engreitz, J. M., Lawson, H. A., Singh, H., Starita, L. M., Hon, G. C., Carter, H., Sahni, N., Reddy, T. E., et al. (2024) · Nature · doi:10.1038/s41586-024-07510-0 · Cited by 88
Rational targeting of a NuRD subcomplex guided by comprehensive in situ mutagenesis
Sher, F., Hossain, M., Seruggia, D., Schoonenberg, V. A. C., Yao, Q., Cifani, P., Dassama, L. M. K., Cole, M. A., Ren, C., Vinjamur, D. S., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0453-4 · Cited by 111
Self-citationIdentification of non-coding silencer elements and their regulation of gene expression
Pang, B., van Weerd, J. H., Hamoen, F. L., & Snyder, M. P. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-022-00549-9 · Cited by 120
Cui, S., Kolodziej, K. E., Obara, N., Amaral-Psarris, A., Demmers, J., Shi, L., Engel, J. D., Grosveld, F., Strouboulis, J., & Tanabe, O. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05310-11 · Cited by 112
Emerging genetic therapy for sickle cell disease
Orkin, S. H., & Bauer, D. E. (2019) · Annual Review of Medicine · doi:10.1146/annurev-med-041817-125507 · Cited by 119
Self-citationHirschhorn, J. N., & Gajdos, Z. K. Z. (2010) · Annual Review of Medicine · doi:10.1146/annurev.med.091708.162036 · Cited by 119
Self-citationUpdate on fetal hemoglobin gene regulation in hemoglobinopathies
Bauer, D. E., & Orkin, S. H. (2011) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e3283420fd0 · Cited by 108
Self-citationTargeted Therapeutic Strategies for Fetal Hemoglobin Induction
Sankaran, V. G. (2011) · Hematology · doi:10.1182/asheducation-2011.1.459 · Cited by 117
Self-citationWake-up Sleepy Gene: Reactivating Fetal Globin for β-Hemoglobinopathies
Wienert, B., Martyn, G. E., Funnell, A. P. W., Quinlan, K. G. R., & Crossley, M. (2018) · Trends in Genetics · doi:10.1016/j.tig.2018.09.004 · Cited by 115
Madzo, J., Liu, H., Rodriguez, A., Vasanthakumar, A., Sundaravel, S., Caces, D. B. D., Looney, T. J., Zhang, L., Lepore, J. B., Macrae, T., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2013.11.044 · Cited by 99
Investigating monogenic and complex diseases with pluripotent stem cells
Zhu, H., Lensch, M. W., Cahan, P., & Daley, G. Q. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2951 · Cited by 115
EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression
Renneville, A., Van Galen, P., Canver, M. C., McConkey, M., Krill-Burger, J. M., Dorfman, D. M., Holson, E. B., Bernstein, B. E., Orkin, S. H., Bauer, D. E., et al. (2015) · Blood · doi:10.1182/blood-2015-06-649087 · Cited by 109
Self-citationRecent progress in understanding and manipulating haemoglobin switching for the haemoglobinopathies
Vinjamur, D. S., Bauer, D. E., & Orkin, S. H. (2018) · British Journal of Haematology · doi:10.1111/bjh.15038 · Cited by 114
Self-citationCurrent and future alternative therapies for beta-thalassemia major
Dreuzy, E. D., Bhukhai, K., Leboulch, P., & Payen, E. (2016) · Biomedical Journal · doi:10.1016/j.bj.2015.10.001 · Cited by 115
Lentiviral and genome-editing strategies for the treatment of β-hemoglobinopathies
Magrin, E., Miccio, A., & Cavazzana, M. (2019) · Blood · doi:10.1182/blood.2019000949 · Cited by 114
Pule, G. D., Mowla, S., Novitzky, N., Wiysonge, C. S., & Wonkam, A. (2015) · Expert Review of Hematology · doi:10.1586/17474086.2015.1078235 · Cited by 113
Gene therapy for sickle cell disease: moving from the bench to the bedside
Abraham, A., & Tisdale, J. F. (2021) · Blood · doi:10.1182/blood.2019003776 · Cited by 111
Chapin, J. C., & Giardina, P. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35762-3.00040-8 · Cited by 108
Wilber, A., Hargrove, P. W., Kim, Y.-S., Riberdy, J. M., Sankaran, V. G., Papanikolaou, E., Georgomanoli, M., Anagnou, N. P., Orkin, S. H., Nienhuis, A. W., et al. (2011) · Blood · doi:10.1182/blood-2010-08-300723 · Cited by 99
Self-citationFrameshift indels introduced by genome editing can lead to in-frame exon skipping
Lalonde, S., Stone, O. A., Lessard, S., Lavertu, A., Desjardins, J., Beaudoin, M., Rivas, M. A., Stainier, D. Y. R., & Lettre, G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178700 · Cited by 108
Self-citationRecent trends in the gene therapy of β-thalassemia
Gambari, R., Finotti, A., Breda, L., Lederer, C. W., Bianchi, N., Zuccato, C., Klenathous, M., & Rivella, S. (2015) · Journal of Blood Medicine · doi:10.2147/jbm.s46256 · Cited by 106
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation
Basak, A., Munschauer, M., Lareau, C. A., Montbleau, K. E., Ulirsch, J. C., Hartigan, C. R., Schenone, M., Lian, J., Wang, Y., Huang, Y., et al. (2020) · Nature Genetics · doi:10.1038/s41588-019-0568-7 · Cited by 105
Self-citationEpigenetic regulation of fetal globin gene expression in adult erythroid cells
Ginder, G. D. (2014) · Translational research · doi:10.1016/j.trsl.2014.05.002 · Cited by 105
Fetal haemoglobin in sickle-cell disease: from genetic epidemiology to new therapeutic strategies
Lettre, G., & Bauer, D. E. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01341-0 · Cited by 104
Self-citationHeme-regulated eIF2α kinase in erythropoiesis and hemoglobinopathies
Chen, J.-J., & Zhang, S. (2019) · Blood · doi:10.1182/blood.2019001915 · Cited by 103
Molecular Basis and Genetic Modifiers of Thalassemia
Tesio, N., & Bauer, D. E. (2023) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.12.001 · Cited by 103
Mi2β-mediated silencing of the fetal γ-globin gene in adult erythroid cells
Amaya, M., Desai, M., Gnanapragasam, M. N., Wang, S. Z., Zu Zhu, S., Williams, D. C., & Ginder, G. D. (2013) · Blood · doi:10.1182/blood-2012-11-466227 · Cited by 102
Wilson, M. C., Trakarnsanga, K., Heesom, K. J., Cogan, N. M., Green, C. A., Toye, A. M., Parsons, S. F., Anstee, D. J., & Frayne, J. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.057315 · Cited by 102
Sheehan, V., Luo, Z., Flanagan, J. M., Howard, T. A., Thompson, B. W., Wang, W. C., Kutlar, A., Ware, R. E., & BABY HUG Investigators (2013) · American Journal of Hematology · doi:10.1002/ajh.23457 · Cited by 102
Visnapuu, M., & Greene, E. C. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1655 · Cited by 102
Li, C., Georgakopoulou, A., Mishra, A., Gil, S., Hawkins, R. D., Yannaki, E., & Lieber, A. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003702 · Cited by 101
Erythroid phenotypes associated with KLF1 mutations
Borg, J., Patrinos, G. P., Felice, A. E., & Philipsen, S. (2011) · Haematologica · doi:10.3324/haematol.2011.043265 · Cited by 101
Bhatnagar, P., Purvis, S., Barron-Casella, E., DeBaun, M. R., Casella, J. F., Arking, D. E., & Keefer, J. R. (2011) · Journal of Human Genetics · doi:10.1038/jhg.2011.12 · Cited by 90
Artificial miRNAs as therapeutic tools: Challenges and opportunities
Kotowska‐Zimmer, A., Pewińska, M., & Olejniczak, M. (2021) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1640 · Cited by 101
Transcription factor competition at the γ-globin promoters controls hemoglobin switching
Liu, N., Xu, S., Yao, Q., Zhu, Q., Kai, Y., Hsu, J. Y., Sakon, P., Pinello, L., Yuan, G.-C., Bauer, D. E., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00798-y · Cited by 86
Self-citationRank, G., Cerruti, L., Simpson, R. J., Moritz, R. L., Jane, S. M., & Zhao, Q. (2010) · Blood · doi:10.1182/blood-2009-10-251116 · Cited by 95
Xiang, J., Wu, D.-C., Chen, Y., & Paulson, R. F. (2015) · Blood · doi:10.1182/blood-2014-07-591453 · Cited by 98
A molecular glue degrader of the WIZ transcription factor for fetal hemoglobin induction
Ting, P. Y., Borikar, S., Kerrigan, J. R., Thomsen, N. M., Aghania, E., Hinman, A. E., Reyes, A., Pizzato, N., Fodor, B. D., Wu, F., et al. (2024) · Science · doi:10.1126/science.adk6129 · Cited by 97
ZNF410 Uniquely Activates the NuRD Component CHD4 to Silence Fetal Hemoglobin Expression
Lan, X., Ren, R., Feng, R., Ly, L. C., Lan, Y., Zhang, Z., Aboreden, N. G., Qin, K., Horton, J. R., Grevet, J. D., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.11.006 · Cited by 97
Genetic association studies in β-hemoglobinopathies
Thein, S. L. (2013) · Hematology · doi:10.1182/asheducation-2013.1.354 · Cited by 79
Sox6, jack of all trades: A versatile regulatory protein in vertebrate development
Hagiwara, N. (2011) · Developmental Dynamics · doi:10.1002/dvdy.22639 · Cited by 95
Potent and uniform fetal hemoglobin induction via base editing
Mayuranathan, T., Newby, G. A., Feng, R., Yao, Y., Mayberry, K. D., Lazzarotto, C. R., Li, Y., Levine, R. M., Nimmagadda, N., Dempsey, E., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01434-7 · Cited by 93
ZNF410 represses fetal globin by singular control of CHD4
Vinjamur, D. S., Yao, Q., Cole, M. A., McGuckin, C., Ren, C., Zeng, J., Hossain, M. A., Luk, K., Wolfe, S. A., Pinello, L., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00843-w · Cited by 89
MicroRNA-96 Directly Inhibits γ-Globin Expression in Human Erythropoiesis
Azzouzi, I., Moest, H., Winkler, J., Fauchère, J.-C., Gerber, A. P., Wollscheid, B., Stoffel, M., Schmugge, M., & Speer, O. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022838 · Cited by 79
Li, C., Psatha, N., Sova, P., Gil, S., Wang, H., Kim, J., Kulkarni, C., Valensisi, C., Hawkins, R. D., Stamatoyannopoulos, G., et al. (2018) · Blood · doi:10.1182/blood-2018-03-838540 · Cited by 82
Gene therapy of hemoglobinopathies: progress and future challenges
Ikawa, Y., Miccio, A., Magrin, E., Kwiatkowski, J. L., Rivella, S., & Cavazzana, M. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz172 · Cited by 86
Sahel, D. K., Vora, L. K., Saraswat, A. L., Sharma, S., Monpara, J. D., D’souza, A. A., Mishra, D., Tryphena, K. P., Kawakita, S., Khan, S. U., et al. (2023) · Advanced Science · doi:10.1002/advs.202207512 · Cited by 88
Role of the transcription factor Bcl11b in development and lymphomagenesis
Kominami, R. (2012) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.88.72 · Cited by 86
Wilber, A., Tschulena, U., Hargrove, P. W., Kim, Y.-S., Persons, D. A., Barbas, C. F., & Nienhuis, A. W. (2010) · Blood · doi:10.1182/blood-2009-08-240556 · Cited by 83
Long-range function of an intergenic retrotransposon
Pi, W., Zhu, X., Wu, M., Wang, Y., Fulzele, S., Eroglu, A., Ling, J., & Tuan, D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004139107 · Cited by 79
Andrades, Á., Peinado, P., Álvarez-Pérez, J. C., Sanjuán‐Hidalgo, J., García, D. J., Arenas, A. M., Matia‐González, A. M., & Medina, P. P. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01736-8 · Cited by 86
Martyn, G. E., Wienert, B., Kurita, R., Nakamura, Y., Quinlan, K. G. R., & Crossley, M. (2019) · Blood · doi:10.1182/blood-2018-07-863951 · Cited by 85
Cell and Gene Therapy for the Beta-Thalassemias: Advances and Prospects
Mansilla-Soto, J., Riviere, I., Boulad, F., & Sadelain, M. (2016) · Human Gene Therapy · doi:10.1089/hum.2016.037 · Cited by 83
Satta, S., Perseu, L., Moi, P., Asunis, I., Cabriolu, A., Maccioni, L., Demartis, F. R., Manunza, L., Cao, A., & Galanello, R. (2011) · Haematologica · doi:10.3324/haematol.2010.037333 · Cited by 82
An erythroid-specific ATP2B4 enhancer mediates red blood cell hydration and malaria susceptibility
Lessard, S., Gatof, E. S., Beaudoin, M., Schupp, P. G., Sher, F., Ali, A., Prehar, S., Kurita, R., Nakamura, Y., Baena, E., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci94378 · Cited by 82
Self-citationFetal γ-globin genes are regulated by the BGLT3 long noncoding RNA locus
Ivaldi, M. S., Diaz, L. F., Chakalova, L., Lee, J., Krivega, I. V., & Dean, A. (2018) · Blood · doi:10.1182/blood-2018-07-862003 · Cited by 82
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy
Srivastava, A., & Velayudhan, S. R. (2016) · Haematologica · doi:10.3324/haematol.2015.141200 · Cited by 81
Li, C., Wang, H., Georgakopoulou, A., Gil, S., Yannaki, E., & Lieber, A. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.09.001 · Cited by 80
Three fingers on the switch: Krüppel-like factor 1 regulation of γ-globin to β-globin gene switching
Tallack, M. R., & Perkins, A. C. (2013) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32835f59ba · Cited by 80
Thalassemia: An Overview of 50 Years of Clinical Research
Sankaran, V. G., & Nathan, D. G. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.08.009 · Cited by 80
Self-citationWoodworth, M. B., Greig, L. C., Liu, K. X., Ippolito, G. C., Tucker, H. O., & Macklis, J. D. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.03.064 · Cited by 79
Park, M. A., Kumar, A., Jung, H. S., Uenishi, G. I., Moskvin, O. V., Thomson, J. A., & Slukvin, I. I. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.04.092 · Cited by 79
Insel, T. R., Sahakian, B. J., Voon, V., Nye, J., Brown, V. J., Altevogt, B. M., Bullmore, E. T., Goodwin, G. M., Howard, R. J., Kupfer, D. J., et al. (2012) · Nature · doi:10.1038/483269a · Cited by 70
BCL11A: a potential diagnostic biomarker and therapeutic target in human diseases
Yin, J., Xie, X., Ye, Y., Wang, L., & Che, F. (2019) · Bioscience Reports · doi:10.1042/bsr20190604 · Cited by 77
Funnell, A. P. W., Prontera, P., Ottaviani, V., Piccione, M., Giambona, A., Maggio, A., Ciaffoni, F., Stehling-Sun, S., Marra, M., Masiello, F., et al. (2015) · Blood · doi:10.1182/blood-2015-04-638528 · Cited by 70
Khosravi, M. A., Abbasalipour, M., Concordet, J., Berg, J. V., Zeinali, S., Arashkia, A., Azadmanesh, K., Buch, T., & Karimipoor, M. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.04.042 · Cited by 76
Ray, J. P., de Boer, C. G., Fulco, C. P., Lareau, C. A., Kanai, M., Ulirsch, J. C., Tewhey, R., Ludwig, L. S., Reilly, S. K., Bergman, D. T., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15022-4 · Cited by 76
Structural variations, the regulatory landscape of the genome and their alteration in human disease
Spielmann, M., & Mundlos, S. (2013) · BioEssays · doi:10.1002/bies.201200178 · Cited by 64
Gene Therapy for Hemoglobinopathies
Chandrakasan, S., & Malik, P. (2014) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2013.12.003 · Cited by 62
John, A., Brylka, H., Wiegreffe, C., Simon, R., Liu, P., Jüttner, R., Crenshaw, E. B., Luyten, F. P., Jenkins, N. A., Copeland, N. G., et al. (2012) · Development · doi:10.1242/dev.072850 · Cited by 71
Trakarnsanga, K., Wilson, M. C., Lau, W. W. Y., Singleton, B. K., Parsons, S. F., Sakuntanaga, P., Kurita, R., Nakamura, Y., Anstee, D. J., & Frayne, J. (2014) · Haematologica · doi:10.3324/haematol.2014.110155 · Cited by 76
Nguyen, T. K. T., Joly, P., Bardel, C., Moulsma, M., Bonello‐Palot, N., & Francina, A. (2010) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2010.04.002 · Cited by 75
Moody, R. R., Lo, M.-C., Meagher, J. L., Lin, C.-C., Stevers, N. O., Tinsley, S. L., Jung, I., Matvekas, A., Stuckey, J. A., & Sun, D. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.811463 · Cited by 68
2021 update on clinical trials in β‐thalassemia
Musallam, K. M., Bou‐Fakhredin, R., Cappellini, M. D., & Taher, A. T. (2021) · American Journal of Hematology · doi:10.1002/ajh.26316 · Cited by 74
Transcriptional silencing of fetal hemoglobin by BCL11A
Sankaran, V. G., Xu, J., & Orkin, S. H. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05574.x · Cited by 75
Self-citationKuo, T., Hong, C., & Hsueh, Y. (2009) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2009.07.006 · Cited by 74
Greig, L. C., Woodworth, M. B., Greppi, C., & Macklis, J. D. (2016) · Neuron · doi:10.1016/j.neuron.2016.03.008 · Cited by 73
Brendel, C., Negre, O., Rothe, M., Guda, S., Parsons, G., Harris, C., McGuinness, M., Abriss, D., Tsytsykova, A., Klatt, D., et al. (2020) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2020.03.015 · Cited by 72
Salem, N. A., Mahnke, A. H., Konganti, K., Hillhouse, A., & Miranda, R. C. (2021) · iScience · doi:10.1016/j.isci.2021.102439 · Cited by 72
Fetal Globin Gene Repressors as Drug Targets for Molecular Therapies To Treat the β-Globinopathies
Suzuki, M., Yamamoto, M. P., & Engel, J. D. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00714-14 · Cited by 72
Metformin induces FOXO3-dependent fetal hemoglobin production in human primary erythroid cells
Zhang, Y., Paikari, A., Sumazin, P., Summarell, C. C. G., Crosby, J. R., Boerwinkle, E., Weiss, M. J., & Sheehan, V. (2018) · Blood · doi:10.1182/blood-2017-11-814335 · Cited by 72
An Update on the Application of CRISPR Technology in Clinical Practice
Morshedzadeh, F., Ghanei, M., Lotfi, M., Ghasemi, M., Ahmadi, M., Najari-Hanjani, P., Sharif, S., Mozaffari‐Jovin, S., Peymani, M., & Abbaszadegan, M. R. (2023) · Molecular Biotechnology · doi:10.1007/s12033-023-00724-z · Cited by 71
Regulation of the fetal hemoglobin silencing factor BCL11A
Basak, A., & Sankaran, V. G. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13024 · Cited by 70
Self-citationGenetic Basis and Genetic Modifiers of β-Thalassemia and Sickle Cell Disease
Thein, S. L. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-7299-9_2 · Cited by 70
Towards a new era in medicine: therapeutic genome editing
Porteus, M. H. (2015) · Genome Biology · doi:10.1186/s13059-015-0859-y · Cited by 69
Low, J. K. K., Silva, A. P. G., Sharifi Tabar, M., Torrado, M., Webb, S. R., Parker, B. L., Sana, M., Smits, C., Schmidberger, J. W., Brillault, L., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108450 · Cited by 66
Doerfler, P. A., Feng, R., Li, Y., Palmer, L. E., Porter, S. N., Bell, H. W., Crossley, M., Pruett‐Miller, S. M., Cheng, Y., & Weiss, M. J. (2021) · Nature Genetics · doi:10.1038/s41588-021-00904-0 · Cited by 69
Mapping genotypes to chromatin accessibility profiles in single cells
Izzo, F., Myers, R. M., Ganesan, S., Mekerishvili, L., Kottapalli, S., Prieto, T., Eton, E. O., Botella, T., Dunbar, A. J., Bowman, R. L., et al. (2024) · Nature · doi:10.1038/s41586-024-07388-y · Cited by 61
Current understanding of human genetics and genetic analysis of psoriasis
Oka, A., Mabuchi, T., OZAWA, A., & Inoko, H. (2012) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2012.01504.x · Cited by 69
Erythro-megakaryocytic transcription factors associated with hereditary anemia
Crispino, J. D., & Weiss, M. J. (2014) · Blood · doi:10.1182/blood-2014-01-453167 · Cited by 69
Hematopoietic Stem Cell Gene-Addition/Editing Therapy in Sickle Cell Disease
Germino-Watnick, P., Hinds, M., Le, A., Chu, R., Liu, X., & Uchida, N. (2022) · Cells · doi:10.3390/cells11111843 · Cited by 68
Sripichai, O., Kiefer, C. M., Bhanu, N. V., Tanno, T., Noh, S.-J., Goh, S.-H., Russell, J. E., Rognerud, C. L., Ou, C.-N., Oneal, P. A., et al. (2009) · Blood · doi:10.1182/blood-2009-05-219386 · Cited by 59
BCL11A enhancer–edited hematopoietic stem cells persist in rhesus monkeys without toxicity
Demirci, S., Zeng, J., Wu, Y., Uchida, N., Shen, A. H., Pellin, D., Gamer, J., Yapundich, M., Drysdale, C., Bonanno, J., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci140189 · Cited by 66
Metadata
- Authors
- Sankaran, V. G., Menne, T. F., Xu, J., Akie, T. E., Lettre, G., Van Handel, B., Mikkola, H. K. A., Hirschhorn, J. N., Cantor, A. B., & Orkin, S. H.
- Affiliations
- Broad Institute (US)
- Division of Hematology/Oncology, Children's Hospital Boston, Harvard Stem Cell Institute, Harvard Medical School, Boston, MA 02115, USA.
- Corresponding author
- Orkin, Stuart H.
- ORCID
- Venue
- Science
- Published
- 2008-12-19
- Volume
- 322
- Issue
- 5909
- Pages
- 1839-1842
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1968165696
- Semantic Scholar
- a52e99500fd26811a2ae248d6dce95e3152b5bb7
- Cited by
- 919
- References
- 27
- Citations by year
- 2026: 59 · 2025: 46 · 2024: 55 · 2023: 52 · 2022: 47 · 2021: 73 · 2020: 70 · 2019: 31 · 2018: 50 · 2017: 59 · 2016: 63 · 2015: 46 · 2014: 45 · 2013: 53 · 2012: 49
- FWCI
- 18.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- National Heart, Lung, and Blood Institute (HL32262-26, P01HL032262, R01HL032259, HL32259-27)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Keywords
- fetal hemoglobin, BCL11A, globin gene regulation, beta-globin gene cluster, sickle cell disease, beta-thalassemia, erythroid cells, therapeutic target
- MeSH terms
- Animals, Carrier Proteins, Cells, Cultured, Erythroblasts, Erythropoiesis, Fetal Hemoglobin, Gene Expression Regulation, Multigene Family, Hemoglobinopathies, Histone Deacetylases, Humans, Nuclear Proteins, Repressor Proteins, Transcription Factors, Transcription, Genetic, Down-Regulation, Erythroid Precursor Cells, K562 Cells, Protein Isoforms, Polymorphism, Single Nucleotide, RNA Interference, Erythroid Cells, Cell Line, Tumor, GATA1 Transcription Factor, Mice, beta-Globins, gamma-Globins, Mi-2 Nucleosome Remodeling and Deacetylase Complex
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.